ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1783

Reversible Dysregulation of Renal Circadian Rhythm in Lupus Nephritis

Rakesh Mishra 1, Ramalingam Bethunaickan 1, Celine Berthier 2, Zhengzi Yi 3, Joshua Strohl 1, Patricio Huerta 1, Weijia Zhang 4 and Anne Davidson5, 1Feinstein Institute for Medical Research, manhasset, NY, 2University of Michigan, Ann Arbor, MI, 3Mount Sinai School of Medicine, New York, 4Mount Sinai School of Medicine, New York, NY, 5Feinstein Institutes for Medical Research, Manhasset

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Animal models and inflammation, Lupus nephritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: 4M094: SLE – Animal Models (1782–1787)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Circadian rhythm is a universal phenomenon that governs homeostasis of overall organism functioning as well as of individual organs. Circadian regulation of homeostatic functions in the kidneys regulates multiple renal functions including GFR, electrolyte excretion and blood pressure control. The effect of renal pathologic processes such as glomerulonephritis on circadian rhythms is not well described. In the course of genomic profiling of lupus kidneys from several mouse models of lupus nephritis we found abnormal expression of several master transcriptional regulators of circadian rhythm. Our goal was to determine how renal circadian rhythm is disrupted in lupus nephritis and the consequences of this disruption.

Methods: Perfused kidneys were obtained for molecular profiling at 4 hrly intervals over a 24hr period from groups of 5-9 young and nephritic NZB/W F1 mice. Genes with a circadian pattern of expression were identified using RAIN test. The enriched biological functions of the genes with circadian rhythm pattern at different time intervals were determined using REVIGO program. Dysregulated expression of transcriptional regulators Bmal1 and Per2 was confirmed by ELISA of renal lysates. Renal sodium and potassium excretion, urine pH and glucose, serum and urine aldosterone and blood pressure were measured at 4 hrly intervals.  The effect of remission induction on gene expression and renal function was evaluated using the same assays.

Results: We found a major effect of circadian dysregulation on renal metabolic functions in nephritic mice that was not simply due to age or altered sleep-wake cycles including a change in diurnal regulation of fatty acid metabolism, a switch in carbohydrate metabolism from gluconeogenesis to the pentose phosphate pathway, loss of diurnal variation of multiple tubular transporters, altered diurnal sodium excretion, acquisition of a high aldosterone state, increased expression of genes that mediate diurnal control of vascular constriction and reverse blood pressure dipping. This circadian dysregulation was partially reversed by remission induction therapy with correction of the abnormalities in fatty acid and carbohydrate metabolism and of abnormal blood pressure dipping phenotype but significantly less effect on the dysregulation of tubular transporters.

Conclusion: There is a profound alteration of renal circadian rhythms in mice with lupus nephritis leading to multiple adverse effects on renal homeostasis and metabolism as well as blood pressure dipper status that are only appreciated upon multiple sampling of kidneys at sequential intervals. Our study indicates the role of inflammation in causing renal circadian disruption and suggests a potential role for circadian agonists in the treatment of lupus nephritis.   


acr fig


Disclosure: R. Mishra, None; R. Bethunaickan, None; C. Berthier, None; Z. Yi, None; J. Strohl, None; P. Huerta, None; W. Zhang, None; A. Davidson, None.

To cite this abstract in AMA style:

Mishra R, Bethunaickan R, Berthier C, Yi Z, Strohl J, Huerta P, Zhang W, Davidson A. Reversible Dysregulation of Renal Circadian Rhythm in Lupus Nephritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/reversible-dysregulation-of-renal-circadian-rhythm-in-lupus-nephritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reversible-dysregulation-of-renal-circadian-rhythm-in-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology